Organic Process Research & Development · 2010 · 23 citations · 33 references
PharmacyChemistryMedicinal ChemistryDrug DiscoveryLead OptimizationSynthetic Medicinal ChemistryBiopharmaceutical ManufacturingProcess SynthesisAldol CondensationAldol ReactionManufacturingProduct OptimisationStereoselective Aldol Reactions
A potential manufacturing route for the EP 1 antagonist GSK269984B was developed. Four synthetic approaches were examined, and a successful realisation of each is presented. The rationale supporting selection of the preferred route is discussed. This route utilised a phenolic aldol reaction as the key step and relied on selective hydrogenolysis to reduce an intermediate diarylmethanol. Further optimisation of the selected route is presented, delivering GSK269984B in three stages and 46% overall yield from readily available starting materials.
33
David W. Old, John P. Wolfe, Stephen L. Buchwald · Journal of the American Chemical Society · 1998 · 811 citations